Effect of Atorvastatin on Fractional Flow Reserve in Coronary Artery Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Coronary Artery Disease
Interventions
DRUG

Atorvastatin

Lipitor dose titration will be followed by the result of LDL lab test until it meets the target level of LDL. IVUS(optional) and FFR during follow up CAG in 12 months will be measured to evaluate the effect of lipitor.

Trial Locations (4)

Unknown

Ulsan University Hospital, Ulsan

Inje University Ilsan Paik Hospital, Ilsan

Keimyung University Dongsan Medical center, Daegu

Seoul National University Hospital, Seoul

All Listed Sponsors
collaborator

Seoul National University Hospital

OTHER

collaborator

Ulsan University Hospital

OTHER

collaborator

Inje University Ilsan Paik Hospital

OTHER

lead

Keimyung University Dongsan Medical Center

OTHER

NCT01946815 - Effect of Atorvastatin on Fractional Flow Reserve in Coronary Artery Disease | Biotech Hunter | Biotech Hunter